Search

The article offers information on the accomplishments of Chiquita Brooks-LaSure, U.S. President Joseph R. Biden Jr.'s nominee as Administrator for the Centers for Medicare and Medicaid Services. It also discusses her work on four major issues namely coverage expansion and affordability, health equity, surprise billing, and value-based payment.

The article reports that U.S. President Joseph R. Biden, Jr. has started to unwind a policy by former U.S. President Donald Trump that allows states to force low-income residents to work or take part in other community engagement activities to enroll in Medicaid coverage. Topics mentioned include Georgia's partial Medicaid expansion, an increase in the federal share of Medicaid spending during the public health emergency, and inconsistency of work rules with the Medicaid law.

The article reports on the move by the U.S. Centers for Medicare and Medicaid Services (CMS) in January 2021 to pause proposed rules developed under the administration of former President Donald Trump in a bid to review Trump-era regulations. The rules include in-center dialysis coverage requirements for third-party payment programs and increased oversight of accrediting organizations. The aim is to prevent efforts to steer patients into individual market coverage.

The article reports on the executive order issued by U.S. President Joe Biden in January 2021 to mandate the Department of Health & Human Services (HHS) to schedule a special enrollment period for a health plan via the Affordable Care Act (ACA) marketplaces. The HHS also allows enrollment via HealthCare.gov until May 15. Also cited is the comment of the Kaiser Family Foundation (KFF) on the special enrollment period.

The article reports on the proposal by the U.S. government on December 10, 2020 of changes that aim to improve patient and provider access to medical records and reform prior authorization.

The article reports on the expected substantial medical loss ratio rebates that health insurers will pay their customers in 2021 as per data from the U.S. Centers for Medicare & Medicaid Services (CMS).

The article discusses the role of the regulatory system in shaping healthcare agenda if 2020 U.S. president candidate Joseph R. Biden wins the election. It notes that the COVID-19 pandemic and final ruling by the U.S. Supreme Court on Affordable Care Act (ACA) will affect his agenda. It suggests that they could enroll more people in ACA and allow the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention to lead the public health response against the virus.

The article discusses the regulatory priorities that the U.S. President Donald Trump Administration needs to focus on if he is elected to a second term and looks at the legal challenges that would affect these agenda. Topics mentioned include the economic consequences of the COVID-19 pandemic, the demand for lower prescription drug prices, and the expansion of the value-based payment in Medicare and Medicaid programs.

The article reports that the U.S. Centers for Medicare and Medicaid Services has approved the state of Nebraska's Medicaid expansion (ME) waiver with work and wellness requirements for newly eligible beneficiaries. Topics mentioned include the potential benefits for ME enrollees including improved health and better quality of life, and the efforts by the state's leadership to block the expansion.

The article reports that the executive order of U.S. President Donald Trump on surprise billing directs U.S. Department of Health and Human Services to update the Hospital Compare website within six months to inform Medicare beneficiaries about hospital billing practices. Topics include itemized list of services received by patients at discharge, thoughts from Patient Rights Advocate founder Cynthia Fisher on surprise billing, and Trump's attempt to increase market competition in healthcare.

The article discusses the executive orders signed by President Donald Trump on July 24, 2020 that are aimed at lowering the prices of prescription drugs (PD) in the U.S. These include the 340B drug discounts, international reference pricing, and a plan to allow the importation of some PD from Canada by states and drugmakers.

The article reports on the July 17, 2020 decision of the U.S. Court of Appeals for the District of Columbia Circuit that upheld U.S. President Donald Trump's expansion of short-term, limited-duration health plans. Topics discussed include the court's rejection of the argument presented by the Association for Community Affiliated Plans, the intent of the Affordable Care Act (ACA), and the argument that the plans are exempt from many of the ACA's requirements.

The article discusses the price transparency rule being pushed by the administration of U.S. President Donald Trump as part of a broader strategy to deregulate, increase market competition, reorient economic incentives and drive innovation within the healthcare industry.

The article reports on a proposed rule released by the Centers for Medicare & Medicaid Services (CMS) on June 25, 2020 to make permanent changes to telehealth flexibilities for home health providers.

The article reports on the opposition of hospitals, health information technology (IT) organizations and insurers to the U.S. Department of Health & Human Services' (HHS) proposed interoperability rules which will require them to adopt open data-sharing technology.

The article reports on two rules issued by U.S. President Donald Trump that increase price transparency for hospitals and insurers. Topics mentioned include requirement for health systems to make their standard fees available on demand and online, pushback from health systems to prepare for implementing the requirements, and the requirement for hospitals to publish their standard charges online in a machine-readable format under the final rule.

The article mentions the further consideration by the U.S. President Donald Trump administration and Republican states on containing the growth of Medicaid enrollment including requiring able-bodied beneficiaries to work as a condition of coverage, as of November 11, 2019.